Targeted delivery of a designed sTRAIL mutant results in superior apoptotic activity towards EGFR-positive tumor cells

Previously, we have shown that epidermal growth factor receptor (EGFR)-selective delivery of soluble tumor necrosis factor-related apoptosis-inducing ligand (sTRAIL), by genetic fusion to antibody fragment scFv425, enhances the tumor-selective pro-apoptotic activity of sTRAIL. Insight into the respe...

Descripción completa

Detalles Bibliográficos
Autores principales: Bremer, Edwin, de Bruyn, Marco, Samplonius, Douwe F., Bijma, Theo, ten Cate, Bram, de Leij, Lou F. M. H., Helfrich, Wijnand
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2008
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491411/
https://www.ncbi.nlm.nih.gov/pubmed/18504532
http://dx.doi.org/10.1007/s00109-008-0348-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491411/
https://www.ncbi.nlm.nih.gov/pubmed/18504532
http://dx.doi.org/10.1007/s00109-008-0348-9

Ejemplares similares